COMMUNIQUÉS West-GlobeNewswire

City of New Rochelle’s Initiative with AGZA and Quiet Communities Aims to Create Quieter, Healthier Neighborhoods
18/09/2026
Comprehensive program will help the city, landscaping businesses and residents transition from gas-powered landscape equipment to cleaner, quieter battery-electric alternatives LINCOLN, Mass., Sept. 18, 2026 (GLOBE [...]
Why Implant Position Matters Long After Surgery: A Peoria Prosthodontic Perspective
18/09/2026
A Peoria prosthodontic practice explains why implant position, bone, bite, and the final restoration need to be planned together, especially in complex, full-arch, and revision cases. Peoria, AZ, Sept. 18, 2026 (GLOBE [...]
Velocity Clinical Research appoints Justin Starzyk as Chief Executive Officer
18/09/2026
Justin brings more than two decades of experience as a healthcare operator, with a track record of scaling multisite services businesses and delivering strong outcomes for investors Paul Evans continues as Chair of the [...]
XORTX Announces Planned FDA IND Submission for XRx-026 Gout Program Using XORLO™, Targeting USD$700M+ U.S. Gout Market Opportunity
18/09/2026
Investigational New Drug application planned for submission to the U.S. FDA in the fourth quarter of 2026, advancing the Company’s regulatory path toward NDA filing for gout program XRx-026 CALGARY, Alberta, Sept. 18, [...]
TOMI Environmental Solutions Reports Accelerating Growth in SteraMist Service Revenue
18/09/2026
Year-to-date SteraMist iHP Service and Support sales of approximately $1.7 million reflects a roughly 31% increase over full-year 2025, underscoring the growing recurring-revenue contribution of TOMI's contracted [...]
OneMedNet Reports Record Bookings as Faster Fulfillment Begins
18/09/2026
Year-to-date bookings of $16.2 million include a combination of fit-for-purpose multi-modal datasets, datasets-plus-license arrangements, and multi-year platform access licenses; a significant portion of these bookings [...]
Silo Pharma Receives U.S. Patent Allowance for SPC-15 PTSD Treatment, Expanding Intellectual Property Portfolio
18/09/2026
Allowed claims cover compositions and methods for preventing or mitigating stress-induced behavioral responses SARASOTA, FLA., Sept. 18, 2026 (GLOBE NEWSWIRE) -- Silo Pharma (Nasdaq: SILO) (“Silo” or “the Company”), a [...]
Alaunos Therapeutics, Inc. Announces Pricing of Registered Direct Offering priced at-the-market under Nasdaq rules
18/09/2026
FORT LAUDERDALE, Fla., Sept. 18, 2026 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (Nasdaq: TCRT) today announced that it has entered into definitive agreements with institutional investors in a registered direct [...]
Aspen Neuroscience Announces Publication of Sasineprocel Preclinical Data in "Cell Stem Cell"
18/09/2026
Peer-reviewed findings describe reproducible manufacturing, leading-edge genomic quality controls and preclinical evidence supporting clinical development of an autologous iPSC-derived neuron replacement therapy for [...]
Hydration Room Expands Beyond California Opening First Clinic in Texas
18/09/2026
Physician-Founded Clinic Brings Medically-Guided IV and Injection Therapy to Texas IRVINE, CA and DALLAS, TX, Sept. 18, 2026 (GLOBE NEWSWIRE) -- Hydration Room , the physician-founded wellness company known for its [...]
Novartis receives positive CHMP opinion for Cosentyx® in polymyalgia rheumatica (PMR)
18/09/2026
If approved, Cosentyx (secukinumab) will be first IL-17A inhibitor licensed in Europe for adults with polymyalgia rheumatica (PMR), providing new treatment option after steroids¹ Recommendation based on data showing Cos [...]
The Ensign Group, Inc. Declares Quarterly Dividend of $0.0650 Per Share
18/09/2026
SAN JUAN CAPISTRANO, Calif., Sept. 18, 2026 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living [...]
Zealand Pharma receives positive CHMP opinion for Zeydovio™ (glepaglutide) for the treatment of short bowel syndrome
18/09/2026
Press release – No. 16 / 2026 Zealand Pharma receives positive CHMP opinion for Zeydovio™ (glepaglutide) for the treatment of short bowel syndrome The CHMP of the European Medicines Agency has recommended the approval [...]
CDT Partners with QIMA Life Sciences to Evaluate Novel Tapinarof Combinations in Psoriasis and Vitiligo
18/09/2026
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Sept. 18, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today announced that it has entered into a partnership with QIMA Life Sciences, a [...]
Novo’s once-weekly Sogroya® (somapacitan) receives positive CHMP opinion in Europe for children with idiopathic short stature (unexplained shortness)
18/09/2026
If approved, Sogroya® (somapacitan) would be the first and only growth hormone treatment approved for idiopathic short stature in the EU, providing a much-needed treatment option for children and their families affected [...]
CHMP recommends EU approval of Roche’s Ocrevus for children and adolescents with relapsing multiple sclerosis
18/09/2026
Ocrevus addresses a critical need in paediatric neurology as the first high- efficacy anti-CD20 treatment option for people with MS as young as 10 years old In the Phase III OPERETTA 2 study, Ocrevus demonstrated non- [...]
BioStem Technologies Secures Up to $40 Million in a Committed Equity Facility
18/09/2026
POMPANO BEACH, Fla., Sept. 18, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (Nasdaq: BSEM) (“BioStem” or the “Company”), a leading regenerative medicine company focused on the development, manufacturing, and [...]
BlossomHill Therapeutics Reports Second Quarter 2026 Financial Results
18/09/2026
Strengthened balance sheet with successful completion of upsized $168.3 million initial public offering Announced FDA Fast Track designation for BH-30643 for the treatment of advanced EGFR C797S-positive NSCLC SAN DIEGO [...]
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18/09/2026
BEDFORD, Mass., Sept. 18, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular” or the “Company”), an integrated biopharmaceutical company committed to redefining the retina experience, today [...]

Pages